ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Infection Impacts dd-cfDNA in Lung Transplant Recipients

D. Levine1, C. Giner1, C. Pham2, R. Woodward2, A. Roux3

1University of Texas Health System San Antonio, San Antonio, TX, 2CareDX, South San Francisco, CA, 3Pneumology, Adult CF Center and Lung Transplantation Department, Foch Hospital, Suresnes, France

Meeting: 2022 American Transplant Congress

Abstract number: 48

Keywords: Genomic markers, Infection, Lung, Non-invasive diagnosis

Topic: Clinical Science » Lung » 64 - Lung: All Topics

Session Information

Session Name: Infectious Considerations for Lung Transplantation

Session Type: Rapid Fire Oral Abstract

Date: Sunday, June 5, 2022

Session Time: 3:30pm-5:00pm

 Presentation Time: 4:40pm-4:50pm

Location: Hynes Room 210

*Purpose: Infection is the leading cause of death within 1 year post lung transplant. Graft injury secondary to infection is affected by both source and organism. Donor derived cell-free DNA (dd-cfDNA) is a consistent marker of graft injury, but previously reported dd-cfDNA levels with infections have been inconsistent. We compared dd-cfDNA concentrations across different infection types.

*Methods: We reviewed infections in lung transplant recipients (LTR) between 5/2019-6/2021 with paired dd-cfDNA at time of infection. All were confirmed infections (i.e. requiring therapy). Infection source (respiratory vs non-respiratory) and organism were collected. Samples were excluded if there was concurrent ACR, AMR or CLAD at time of dd-cfDNA. The primary endpoint was dd-cfDNA levels across cohorts.

*Results: Fifty paired samples from 20 LTR were identified; 31 samples were excluded due to concurrent diagnoses. Infections included viral (n=18, 36%), bacterial (n=18, 36%), and fungal (n=10, 20%). Four cultures (8%) had multiple organisms. Most common within each group were CMV (n=4) and COVID (n=4) for viral, Pseudomonas aeruginosa (n=4) for bacterial, and Aspergillus (n=7) for fungal. Median dd-cfDNA was 1.30% in viral infections, 1.93% in bacterial, and 0.99% in fungal; respiratory infections (n=42) was 1.42% and 0.95% in non-respiratory (n=8).

*Conclusions: There was a statistically significant increase in dd-cfDNA between each infection compared to a normal cohort, but no statistical differences between infection groups. The trend towards significance of respiratory vs non-respiratory indicates that dd-cfDNA may be a useful marker of injury specific to the graft caused by infection. Further investigation with serial samples prior to and following treatment of the infection will be important to better understand this trend.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Levine D, Giner C, Pham C, Woodward R, Roux A. Infection Impacts dd-cfDNA in Lung Transplant Recipients [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/infection-impacts-dd-cfdna-in-lung-transplant-recipients/. Accessed May 8, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences